Added to YB: 2024-12-30
Pitch date: 2024-12-24
PGNY [bullish]
Progyny, Inc.
+17.28%
current return
Author Info
Directionally Correct Research shares is a generalist hedge fund analyst sharing stock pitches in the small to mid cap space. Sign up for the newsletter.
Company Info
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.
Market Cap
$1.2B
Pitch Price
$14.41
Price Target
26.00 (+54%)
Dividend
N/A
Sector
Health Care Providers and Services
Category
growth
Progyny, Inc. - $PGNY
PGNY: Ex-growth darling, sold off on deceleration & lost client. Still best-in-class in fertility benefits w/ huge TAM. 5.5x 2025 EBITDA, 80%+ FCF conv, 20% mkt cap in cash. High teens growth path, margin expansion. $26 PT (6x 2027 EBITDA), 20%+ 3yr IRR. Re-rate to 8x = 30%+ IRR. Risks: guidance misses, new market execution.
Read full article (9 min)